通过NCDB探索儿科脊椎,神器和骨盆骨肉瘤:人口统计,治疗利用率和生存结果
Pemla Jagtiani1, Mert Karabacak2, Matthew T Carr2
1School of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.
Children (Basel, Switzerland)
|August 29, 2024
概括
这项研究分析了使用国家癌症数据库 (NCDB) 数据的儿科脊椎,圣骨和骨盆骨肉瘤. 关键发现包括影响死亡率和治疗的因素,强调个性化护理以获得更好的结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 骨瘤学 骨瘤学
- 癌症流行病学 癌症流行病学
背景情况:
- 脊椎和骨盆骨肉瘤是罕见的儿科恶性瘤.
- 了解它们的流行病学和治疗对于改善生存至关重要.
研究的目的:
- 调查儿科脊椎,圣骨和骨盆骨肉类瘤的流行病学流行,治疗策略和生存结果.
- 确定影响患者结果的预后因素.
主要方法:
- 对2008-2018年国家癌症数据库 (NCDB) 数据的回顾性审查.
- 分析包括0-21岁的患有脊椎,分骨或骨盆骨髓瘤的患者.
- 统计方法包括后勤回归,Poisson回归,Kaplan-Meier估计和Cox比例危险模型.
主要成果:
- 对于脊椎骨肉瘤,淋巴结参与和远程转移显著增加了死亡风险.
- 对于圣骨和盆骨骨肉瘤,没有残留瘤和接受放射治疗与较低的死亡率有关.
- 远程转移是死亡率的强有力的预测因素;西班牙裔种族与较低的切除几率有关.
结论:
- 国家疾病预防控制局 (NCDB) 的数据提供了宝贵的洞察力,了解儿科的脊椎,分骨和骨盆骨髓瘤.
- 预后因素,如转移和残留疾病影响生存率.
- 个性化治疗方法对于优化这些罕见瘤的治疗结果至关重要.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


